Latest Dilution News

Findi Limited has raised A$25 million through an institutional placement to refinance its Indian subsidiary’s balance sheet, reduce debt, and accelerate its ATM rollout and digital payments growth.

Australian Bond Exchange Holdings has completed a $0.98 million placement and is proposing attaching options to raise additional funds, pending shareholder approval.

Nexalis Therapeutics reported a widening loss of $1.83 million for 2025, reflecting increased investment in product development and marketing. Despite the loss, the company boosted its cash reserves through equity raises and borrowings.

Challenger Gold has initiated ore haulage from its Hualilán Mine to the Casposo Plant, marking a pivotal step in its toll milling strategy aimed at near-term production and cash flow. The company also reports robust resource and reserve updates alongside key infrastructure advancements.

Entropy Neurodynamics reports a 14.8% reduction in half-year losses while progressing a pioneering clinical trial for Binge Eating Disorder using its proprietary psychedelic drug TRP-8803. The company also secured $6.1 million in new funding and strategic collaborations to enhance its neuropsychiatry platform.

Mesoblast Limited reported its first commercial sales of FDA-approved Ryoncil, generating $48.7 million in net product sales for the half-year ended December 31, 2025, while reducing its net loss by 16%. The company also secured a $125 million five-year credit facility, restructuring its debt to support ongoing commercialization and development.

Block, Inc. reported robust financial results for 2025, driven by Cash App and Square growth, while announcing a significant workforce reduction to accelerate AI-driven innovation and efficiency.

GoldArc Resources has locked in a strategic drilling services agreement with MMS for its Leonora South Gold Project, enabling up to A$750,000 of drilling fees to be paid in shares. This innovative deal preserves cash and aligns contractor incentives with the project’s long-term success.

MinRex Resources Limited (ASX: MRR) has announced a definitive agreement to acquire 100% of Electrum Discovery Corp. (TSX-V: ELY) via a statutory Plan of Arrangement, creating a combined ASX-listed gold-copper exploration company with significant assets in Serbia and Australia.

Infotrust Ltd reported a significant $16.5 million half-year loss driven by a $15.6 million impairment on its Cloud and Communications segment, which it plans to divest for up to $50 million. The move refocuses the company on its core Cyber Security business amid steady revenue growth.

BluGlass Limited reported a 14% revenue increase to A$5.76 million and a 28% reduction in net loss to A$4.1 million for H1 FY26, bolstered by a key US Department of War contract extension and a refreshed board driving growth.

Bioxyne Limited has reported a remarkable half-year performance, with revenues soaring 149% to $31.3 million and net profit more than doubling to $7.3 million, driven by strong demand for medicinal cannabis, MDMA, and psilocybin products and expanding international operations.